These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2299254)

  • 1. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs.
    Goodnough LT; Brittenham GM
    J Lab Clin Med; 1990 Jan; 115(1):28-35. PubMed ID: 2299254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation.
    Goodnough LT; Verbrugge D; Marcus RE; Goldberg V
    J Am Coll Surg; 1994 Aug; 179(2):171-6. PubMed ID: 8044386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy.
    Bovy C; Baudoux E; Salmon JP; Beguin Y
    Transfusion; 2006 Sep; 46(9):1616-23. PubMed ID: 16965592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous epoetin alfa as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery.
    Gombotz H
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):69-70; discussion 71-2. PubMed ID: 8723587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron-restricted erythropoiesis as a limitation to autologous blood donation in the erythropoietin-stimulated bone marrow.
    Goodnough LT; Price TH; Rudnick S
    J Lab Clin Med; 1991 Sep; 118(3):289-96. PubMed ID: 1919301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythropoiesis and iron metabolism in autologous blood donation].
    Eckstein R; Emmler J; Fellmer F; Zeiler T; Zimmermann R; Zingsem J; Heuft HG; Kirgis A; Weisbach V
    Infusionsther Transfusionsmed; 1992 Apr; 19(2):56-8. PubMed ID: 1623318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron and erythropoietin measurement in autologous blood donors with anemia: implications for management.
    Tasaki T; Ohto H; Noguchi M; Motoki R; Kikuchi S; Sato A; Hoshino S
    Transfusion; 1994 Apr; 34(4):337-43. PubMed ID: 8178331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous versus allogeneic transfusion: patients' perceptions and experiences.
    Graham ID; Fergusson D; Dokainish H; Biggs J; McAuley L; Laupacis A
    CMAJ; 1999 Apr; 160(7):989-95. PubMed ID: 10207337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward bloodless surgery: erythropoietin therapy in the surgical setting.
    Goodnough LT
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):19-24. PubMed ID: 1615335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epoetin alfa as an adjuvant to autologous blood donation.
    Beris P
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):27-9; discussion 30. PubMed ID: 8723578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoetin alfa plus autologous blood donation and normovolemic hemodilution in patients scheduled for orthopedic or vascular surgery.
    Tryba M
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):34-6; discussion 37-8. PubMed ID: 8723580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous blood donation with recombinant human erythropoietin in cardiac surgery: the Japanese experience.
    Baron JF
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):64-7; discussion 68. PubMed ID: 8723586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of recombinant human erythropoietin therapy on red cell expansion during autologous blood donation.
    Goodnough LT; Marcus RE
    Contemp Orthop; 1994 Dec; 29(6):430-4. PubMed ID: 10150254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoiesis in patients stimulated with erythropoietin: the relevance of storage iron.
    Goodnough LT; Marcus RE
    Vox Sang; 1998; 75(2):128-33. PubMed ID: 9784666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoetin alfa: new directions in orthopedic surgery.
    Beris P
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):60-2; discussion 63. PubMed ID: 8723585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hematologic parameters in repeated autologous blood donation].
    Roos D; Lubitz B; Maring J; Doumanis A; Wittkopf D; Kühnl P
    Beitr Infusionsther; 1990; 26():264-6. PubMed ID: 1703846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood lost and transfused in patients undergoing elective orthopedic operation.
    Goodnough LT; Vizmeg K; Marcus RE
    Surg Gynecol Obstet; 1993 Mar; 176(3):235-8. PubMed ID: 8438194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
    Mercuriali F
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):18-20; discussion 21. PubMed ID: 8723576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative autologous blood deposit and liquid storage for replacement arthroplasty].
    Lorentz A; Schipplick M; Gmehlin U; Osswald PM; Winter M
    Anaesthesist; 1989 Sep; 38(9):480-9. PubMed ID: 2589631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of epoetin alfa in patients in autologous blood donation programs for orthopedic surgery.
    McClelland B
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):2-3; discussion 4. PubMed ID: 8723572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.